Latest return on equity
Xilio Therapeutics Return on equity
Direct answer
Xilio Therapeutics's return on equity is -55.03%.
The verified market snapshot reports -55.03%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 7, 2026.
Get free Xilio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -55.03%
Explore related company data
View Xilio Therapeutics's market capitalizationView Xilio Therapeutics's price-to-book ratioView Xilio Therapeutics's 52-week price rangeView Xilio Therapeutics's revenue growthView Xilio Therapeutics's profit marginView Xilio Therapeutics's debt-to-equity ratioView all Xilio Therapeutics key metricsReturn to Xilio Therapeutics profile